Literature DB >> 29038893

[Daylight photodynamic therapy : Back to the future?]

P Lehmann1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29038893     DOI： 10.1007/s00105-017-4068-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  12 in total

Review 1.  Daylight PDT with MAL - current data and practical recommendations of an expert panel.

Authors:  Wolfgang G Philipp-Dormston; Sigrid Karrer; Holger Petering; Claas Ulrich; Thomas Dirschka; Carola Berking; Anke S Lonsdorf; Peter Arne Gerber; Sonja Radakovic; Robert E Hunger; Rolf-Markus Szeimies
Journal:  J Dtsch Dermatol Ges       Date:  2015-12       Impact factor: 5.584

2.  Phototherapy.

Authors:  Herbert Hönigsmann
Journal:  J Invest Dermatol       Date:  2013-07-01       Impact factor: 8.551

3.  European Dermatology Forum Guidelines on topical photodynamic therapy.

Authors:  Colin Morton; Rolf-Markus Szeimies; Alexis Sidoroff; Ann-Marie Wennberg; Nicole Basset-Seguin; Piergiacomo Calzavara-Pinton; Yolanda Gilaberte; Günther Hofbauer; Robert Hunger; Sigrid Karrer; Percy Lehmann; Stefano Piaserico; Claas Ulrich; Lasse Braathen
Journal:  Eur J Dermatol       Date:  2015 Jul-Aug       Impact factor: 3.328

4.  Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study.

Authors:  C Kellner; S Bauriedl; S Hollstein; U Reinhold
Journal:  Br J Dermatol       Date:  2015-02-25       Impact factor: 9.302

5.  Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

Authors:  Lasse R Braathen; Rolf-Markus Szeimies; Nicole Basset-Seguin; Robert Bissonnette; Peter Foley; David Pariser; Rik Roelandts; Ann-Marie Wennberg; Colin A Morton
Journal:  J Am Acad Dermatol       Date:  2007-01       Impact factor: 11.527

6.  Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.

Authors:  S R Wiegell; M Haedersdal; P A Philipsen; P Eriksen; C D Enk; H C Wulf
Journal:  Br J Dermatol       Date:  2008-02-19       Impact factor: 9.302

7.  Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations.

Authors:  S R Wiegell; S Fabricius; J Heydenreich; C D Enk; S Rosso; W Bäumler; B T Baldursson; H C Wulf
Journal:  Br J Dermatol       Date:  2013-01       Impact factor: 9.302

8.  Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.

Authors:  Susan M O'Gorman; Julianne Clowry; Michael Manley; Jackie McCavana; Linda Gray; Ann Kavanagh; Aoife Lally; Paul Collins
Journal:  JAMA Dermatol       Date:  2016-06-01       Impact factor: 10.282

Review 9.  Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid.

Authors:  C Fritsch; P Lehmann; W Stahl; K W Schulte; E Blohm; K Lang; H Sies; T Ruzicka
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

10.  Alternatives to Outdoor Daylight Illumination for Photodynamic Therapy--Use of Greenhouses and Artificial Light Sources.

Authors:  Catharina M Lerche; Ida M Heerfordt; Jakob Heydenreich; Hans Christian Wulf
Journal:  Int J Mol Sci       Date:  2016-02-29       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.